Nonparalytic botulinum molecules for the control of pain

Mangione, A.S.; Obara, I.; Maiarú, M.; Geranton, S.M.; Tassorelli, C.; Ferrari, E.; Leese, Ch; Davletov, B.; Hunt, S.P.

doi:10.1097/j.pain.0000000000000478

All Outputs (2)

Histamine in diabetes: is it time to reconsider? (2016)
Journal Article
Pini, A., Obara, I., Battell, E., Chazot, P., & Rosa, A. (2016). Histamine in diabetes: is it time to reconsider?. Pharmacological Research, 111, 316-324. https://doi.org/10.1016/j.phrs.2016.06.021

The first studies of histamine and diabetes date back to the 1950s. Since that time the involvement of histamine in diabetes was related to its well known vasoactive properties and permeability leakage effects. In particular, the first evidence for a... Read More about Histamine in diabetes: is it time to reconsider?.

Nonparalytic botulinum molecules for the control of pain (2016)
Journal Article
Mangione, A., Obara, I., Maiarú, M., Geranton, S., Tassorelli, C., Ferrari, E., …Hunt, S. (2016). Nonparalytic botulinum molecules for the control of pain. PAIN, 157(5), 1045-1055. https://doi.org/10.1097/j.pain.0000000000000478

Local injections of botulinum toxins have been reported to be useful not only for the treatment of peripheral neuropathic pain and migraine but also to cause long-lasting muscle paralysis, a potentially serious side effect. Recently, a botulinum A-ba... Read More about Nonparalytic botulinum molecules for the control of pain.